Suzuken Co., Ltd.

Suzuken Co., Ltd.

SZUKF

$30.30

Updated: 23/09/2026, 20:31:28

Market Cap
$2.05B
Sector
Healthcare
Industry
Medical - Distribution
Country
JP
Stock valuation chart
One-year closing share-price history for SZUKF
Company Profile

Suzuken Co., Ltd., along with its affiliated companies, operates primarily as a global wholesaler of pharmaceutical products, with a strong presence both in Japan and internationally. The company's diverse activities are structured into four main divisions: Pharmaceutical Distribution, Pharmaceutical Manufacturing, Pharmacy Services, and Healthcare-Related Services. The Pharmaceutical Distribution segment focuses on sourcing a wide array of items, including prescription medications, diagnostic substances, various medical devices and supplies, and other health-focused goods directly from manufacturers. These products are then supplied to medical facilities and pharmacies. In its Pharmaceutical Manufacturing division, Suzuken engages in the research, development, production, and marketing of ethical pharmaceuticals and diagnostic tools, with a particular emphasis on treatments for diabetes and kidney diseases. Through its Pharmacy Services segment, the company provides support via community pharmacists, while also striving to optimize the operations of local pharmacies and offering essential educational assistance. Finally, the Healthcare-Related Services division offers a broad spectrum of functions. This includes providing support for manufacturers, such as outsourced distribution and the specialized distribution of orphan drugs, in addition to delivering nursing care services. This segment is also responsible for the design, manufacturing, and sale of medical instruments like ECG machines, blood pressure monitors, and stethoscopes, as well as general medical materials and equipment for health promotion. Beyond these core business areas, Suzuken Co., Ltd. also publishes medical periodicals specifically for healthcare professionals and institutions. The company has also forged a strategic alliance with Bushu Pharmaceuticals Ltd. to offer specialized contract drug services. Suzuken Co., Ltd. was established in 1932 and is headquartered in Nagoya, Japan.

USD
OTC
CEO: Shigeru Asano
Employees: 12,717
https://www.suzuken.co.jp
Asset Summaries
Latest generated summaries for SZUKF

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for SZUKF.
Share price
$30.30
Market cap
$2.05B
Exchange
OTC
Currency
USD
CEO
Shigeru Asano
Employees
12,717
IPO date
10/09/2013
Beta
0.227
Last dividend
$0.00
Day range
$30.30 – $30.30
52-week range
$30.30 – $30.30
1-day performance
0.00%
1-year performance
0.00%
Current drawdown (1Y)
0.00%
CIK
N/A
CUSIP
N/A
ISIN
JP3398000004
Created
07/12/2025, 14:28:59
Last update
23/09/2026, 20:31:28

Track Suzuken Co., Ltd. with an AI analyst

See which prediction-market events move SZUKF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to SZUKF from your Railway `news_articles` table.

No news found for this symbol.